Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Glumetza Patent Settlement Without An Authorized Generic Plus Price Hike Spawns Litigation
Dec 03 2019
•
By
Brenda Sandburg
Walgreen and other direct purchasers and end payers allege Glumetza patent litigation settlement led to Valeant price hike
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Legal & IP
More from Pink Sheet